Title: Counterfeit and substandard Chinese herbal medicines are rampant and harming people
Author: Han Shaobai
Date: 1989-07-20
Edition: 2

Some unscrupulous elements are taking advantage of the country's policy of opening up and reform to peddle fake and substandard Chinese herbal medicines, seriously harming the public and seeking huge profits. The Ministry of Health has decided to immediately conduct a nationwide quality inspection of a batch of key Chinese herbal medicines. These include yam, poria, toad venom, American ginseng, styrax, gold coin grass, agarwood, sappan wood, rhinoceros horn, and myrrh. Any that do not meet pharmaceutical standards will be confiscated on the spot and dealt with strictly in accordance with the "Pharmaceutical Administration Law."

The Ministry of Health also announced the revocation of local standards for 768 varieties of patent Chinese medicines, including "Hongshengdan," "Joint Pain Pills," and "Compound Yunnan Baiyao Capsules." This is to address the current chaos in China's patent Chinese medicines, where formulations are irrational, efficacy is not genuine, and names and formulations are inconsistent.


<hr /> 

Original: 


### 伪劣中药材泛滥坑人  卫生部决定重点清查  同时撤销768种中成药地方标准
韩少白
1989-07-20
第2版(国内新闻)
专栏：

    伪劣中药材泛滥坑人
    卫生部决定重点清查
    同时撤销768种中成药地方标准
    本报北京7月20日讯　由于目前社会上一些不法分子利用开放搞活之机，故意兜售一些假劣中药坑害群众牟取暴利的情况非常严重，卫生部决定立即在全国范围内对一批重点中药材品种进行一次质量大检查。如山药、茯苓、蟾酥、西洋参、苏合香、金钱草、沉香、苏木砂仁、鹿鞭、没药等，凡不符药用要求者均就地没收，照《药品管理法》规定严肃处理。
    卫生部还同时宣布撤销“红升丹”、“关节炎片”、“复方三七胶囊”等768种中成药地方标准，以解决目前我国中成药品种中组方不合理、疗效不切实和名称各异又组方不一等混乱问题。　			（韩少白）
